This grant is for the purpose of funding innovative research that expands or modifies current approaches in ovarian cancer. The Department of Defense’s Pilot Award seeks to explore novel concepts and theories that can lead to critical discoveries and major advancements, driving the field forward. Innovation is paramount; projects must demonstrate exceptional creativity beyond mere scientific merit. Preliminary data are not a prerequisite but can be included. This award supports a range of research phases, from foundational laboratory studies to translational research, specifically excluding clinical trials. The aim is to foster groundbreaking work that redefines understanding and treatment strategies for ovarian cancer.
Opportunity ID: 358734
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | HT942525OCRPPA |
| Funding Opportunity Title: | DOD Ovarian Cancer, Pilot Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 9 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 22, 2025 |
| Last Updated Date: | Apr 22, 2025 |
| Original Closing Date for Applications: | Sep 11, 2025 |
| Current Closing Date for Applications: | Sep 11, 2025 |
| Archive Date: | Oct 11, 2025 |
| Estimated Total Program Funding: | $3,150,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: |
Summary: Supports research that expands or modifies current thinking about and/or approaches in ovarian cancer, exploring innovative concepts or theories in ovarian cancer that could ultimately lead to critical discoveries or major advancements that will drive the field forward. Distinctive Features: Innovation is key. Research projects that demonstrate exceptional scientific merit but lack innovation do not meet the intent of the mechanism. Preliminary data are not required but are allowed for this mechanism. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 358734 Full Announcement-FY25 OCRP PA -> HT942525OCRPPA_GG.pdf
Packages
| Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00290618 | Apr 22, 2025 | Sep 11, 2025 | View |
Package 1
Mandatory forms
358734 RR_SF424_5_0-5.0.pdf
358734 AttachmentForm_1_2-1.2.pdf
358734 RR_PersonalData_1_2-1.2.pdf
358734 RR_KeyPersonExpanded_4_0-4.0.pdf
358734 RR_Budget_3_0-3.0.pdf
358734 PerformanceSite_4_0-4.0.pdf
Optional forms
358734 RR_SubawardBudget30_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
